The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
4
Research Center
Little Rock, Arkansas, United States
Research Center
Tampa, Florida, United States
Research Center
Brooklyn, New York, United States
Research Center
Cleveland, Ohio, United States
Angiographic assessment of the change in the volume of thrombus (Exploratory endpoint)
Time frame: Baseline, 8 and 24 hours
Assessment of the change in TcPO2 (Exploratory endpoint)
Time frame: Baseline, 8, 12, and 24 hours
Number of participants with adverse events
Time frame: Randomization through 30 days post-treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.